LaFleur & Godfrey’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$466K Buy
5,081
+131
+3% +$11.5K 0.06% 109
2026
Q1
$422K Buy
4,950
+150
+3% +$13.4K 0.05% 107
2025
Q4
$379K Hold
4,800
0.05% 115
2025
Q3
$384K Hold
4,800
0.05% 112
2025
Q2
$436K Hold
4,800
0.05% 111
2025
Q1
$450K Hold
4,800
0.06% 108
2024
Q4
$436K Hold
4,800
0.06% 107
2024
Q3
$498K Hold
4,800
0.07% 103
2024
Q2
$466K Hold
4,800
0.07% 104
2024
Q1
$432K Hold
4,800
0.06% 99
2023
Q4
$383K Hold
4,800
0.06% 97
2023
Q3
$341K Hold
4,800
0.05% 98
2023
Q2
$370K Sell
4,800
-146
-3% -$11.3K 0.06% 98
2023
Q1
$372K Hold
4,946
0.06% 99
2022
Q4
$390K Hold
4,946
0.07% 98
2022
Q3
$347K Sell
4,946
-600
-11% -$47K 0.06% 100
2022
Q2
$444K Hold
5,546
0.07% 97
2022
Q1
$421K Hold
5,546
0.06% 103
2021
Q4
$473K Hold
5,546
0.06% 101
2021
Q3
$419K Buy
+5,546
New +$440K 0.06% 105

Other funds holding CL

LaFleur & Godfrey's CL Position: Q2 2026 in Review

LaFleur & Godfrey increased its Colgate-Palmolive (CL) stake by 2.6% in Q2 2026, buying an estimated $11.5K and bringing the position to 5,081 shares worth $466K. The position accounts for 0.06% of the portfolio, ranked #109.

LaFleur & Godfrey first reported a position in CL in Q3 2021 and has held it in 20 quarters since. The position peaked at $498K in Q3 2024. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • LaFleur & Godfrey held 5,081 shares of Colgate-Palmolive worth $466K as of Q2 2026.
  • LaFleur & Godfrey bought 131 Colgate-Palmolive shares in Q2 2026, an estimated $11.5K.
  • Colgate-Palmolive made up 0.06% of LaFleur & Godfrey's portfolio in Q2 2026, its #109 holding.
  • LaFleur & Godfrey first reported a position in Colgate-Palmolive in Q3 2021 and has held it in 20 quarters since.
  • LaFleur & Godfrey's Colgate-Palmolive position peaked at $498K in Q3 2024.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on LaFleur & Godfrey's 13F filing for Q2 2026, filed 15 Jul 2026.